Efforts ‘shift the dial’ on the pain meds shortage

alert warning
Steps are being made towards access to morphine oral solution – and an announcement may be on its way in the near future Mundpharma has written to advise of an update following its June 2023 announcement that it would discontinue all four strengths of its Ordine (immediate release morphine hydrochloride) solution. Earlier this month (January

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Some Australians ‘missing out’ on pharmacist prescribing trial access
Next Silos, restrictions and inconsistency named as scope barriers